1) How many patients at your trust have been supplied medicines approved through the Early Access to Medicines Scheme (EAMS) each year between April 2014 and April 2023?
2) How many requests has your trust made to pharmaceutical companies for access to medicines offered through a company-led ‘compassionate use’ or ‘free of charge’ scheme each year between April 2014 and April 2023?
a. How many patients have received treatment with unlicensed medicines obtained this way each year between April 2014 and April 2023?
3) How many requests have clinicians at your trust submitted to pharmaceutical companies for access to an unlicensed medicine to treat patients each year between April 2014 and April 2023, outside of a company-led scheme?
a. How many patients have received treatment with unlicensed medicines obtained this way each year between April 2014 and April 2023?
